The Recombinant Therapeutic Antibodies And Proteins Market Is Estimated To Witness High Growth Owing To Increasing Use In Targeted Cancer Therapy

 

Recombinant Therapeutic Antibodies And Proteins Market 

Recombinant therapeutic antibodies and proteins are important biopharmaceutical products used for disease treatment and management. They are produced through recombinant DNA technology by genetically engineered cell lines such as bacteria, yeast, and mammalian cells. Antibodies act as targeted therapies whereas proteins are used to replace deficient or missing human proteins, helping treat conditions such as cancer, autoimmune diseases, cardiovascular diseases, hemophilia and other genetic disorders.

The global Recombinant Therapeutic Antibodies And Proteins Market is estimated to be valued at US$ 185.95 Bn in 2023 and is expected to exhibit a CAGR of 12% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:


The recombinant therapeutic antibodies and proteins market is expected to grow at a significant rate, owing to increasing use of monoclonal antibodies for targeted cancer therapy. According to World Health Organization, cancer accounted for nearly 10 million deaths in 2020 and is a leading cause of death worldwide. Monoclonal antibodies have revolutionized cancer treatment by selectively targeting tumor cells and proteins while minimizing damage to normal cells. Another major driver is the increasing prevalence of autoimmune diseases globally. For example, according to National Institutes of Health, about 23.5 million Americans suffered from autoimmune diseases in 2015. Biologics and therapeutic proteins are important treatment options for various autoimmune conditions. However, high development and manufacturing costs of biologics pose a challenge to market growth.

SWOT Analysis

Strength: Explain in three sentence explanation: Recombinant therapeutic antibodies and proteins offer precise treatment with minimized side-effects. They enable detection and prevention of various diseases like cancer, infectious diseases. Recombinant technology allows mass production of these antibodies and proteins in a more effective and economical manner.
Weakness: Explain two weakness in three sentence long explanation: High costs involved in R&D and production of recombinant therapeutic antibodies and proteins make them inaccessible for some patients. Storage and transportation of these molecules require strict temperature controls which increases logistical challenges and costs.
Opportunity: Explain two opportunity in three sentence long explanation: Growing prevalence of chronic diseases and various types of cancer presents huge market potential. Emerging economies provide lucrative opportunities owing to their large patient population and improving healthcare spending.
Threats: Explain two threats two sentence explanation: Stringent regulatory norms can delay approvals and market entry. Patent expiries of blockbuster drugs lead to decline in revenues of innovator companies.

Key Takeaways
The global Recombinant Therapeutic Antibodies And Proteins Market Share is expected to witness high growth, exhibiting CAGR of 12% over the forecast period, due to increasing burden of chronic diseases. North America is currently the dominant as well as the fastest growing regional market owing to established healthcare infrastructure and rising healthcare expenditure in the US and Canada. Europe also captured significant market share due to presence of key market players and favorable reimbursement policies for expensive biologics.

Regional analysis
Asia Pacific is anticipated to exhibit highest growth rate over the coming years. Growing unmet medical needs, rising healthcare spending, and expanding access to healthcare insurance are major factors driving the APAC market.

Key players
Key players operating in the recombinant therapeutic antibodies and proteins market are Roche, Johnson & Johnson, Novartis, and Amgen. The market is fairly concentrated with these major players collectively accounting for over 50% share. Large companies are continuously investing in R&D to develop novel molecules and gain first-mover advantages.

For more details on the report, Read-

https://www.pressreleasebulletin.com/recombinant-therapeutic-antibodies-and-proteins-market/

Comments

Post a Comment

Popular posts from this blog

The Bladder Liners Market Is Estimated To Witness High Growth Owing To Rising Prevalence Of Urinary Incontinence

Image
  Bladder Liners Market Market Overview: Benzodiazepines are a class of psychoactive drugs belonging to the benzodiazepine family. These drugs are prescribed for various medical conditions such as anxiety disorders, panic disorders, insomnia, seizures, alcohol withdrawal syndrome, muscle spasms, and as an anesthesia aid. Some common examples of benzodiazepines include alprazolam, clonazepam, diazepam, and lorazepam. These drugs work by increasing the action of gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the central nervous system. Due to their calming properties, they are widely used to treat insomnia, anxiety, panic attacks, agitation, seizures, muscle spasms, and alcohol withdrawal. Market Dynamics: The Benzodiazepine Drugs Market is primarily driven by the rising prevalence of anxiety disorders worldwide. As per Anxiety and Depression Association of America, anxiety disorders are the most common mental illness in the U.S., affecting nearly 40 million ...
Read more

The Global Electric Powertrain Market Poised for Growth Driven by Sustainable Transportation

Image
  Electric Powertrain Market The global electric powertrain market is seeing rapid adoption as consumers seek more environmentally friendly transportation options. Electric powertrains offer much lower operating costs than internal combustion engines while also being more energy efficient with fewer moving parts. Battery electric vehicles and hybrids containing electric motors and batteries are able to deliver torque instantly for smooth acceleration and regenerative braking that captures kinetic energy to charge the batteries while slowing down. Automakers are developing advanced powertrain technologies that combine smaller, lighter electric motors with improved batteries capable of longer ranges between charges. The global Electric Powertrain Market is estimated to be valued at US$ 94.12 Mn in 2024 and is expected to exhibit a CAGR of 4.9% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: One of the ...
Read more

Poultry Market is Expected to be Flourished by Growing Demand for Protein-Rich Food

Image
Poultry Market The poultry market comprises farming of domesticated birds such as chickens, ducks, turkeys, and geese, primarily for their meat and eggs. Poultry meat is one of the most consumed meats globally owing to its high protein content. Chicken is the most commonly produced meat worldwide, with over 95 million tons produced annually. Poultry farming provides affordable animal protein to consumers while generating income and employment for farmers and allied industries. The global poultry industry includes large integrated production facilities, small commercial farms, and backyard flock operations. Technological advancements have increased efficiency in breeding, hatching, feeding, housing, and disease control. The global poultry market is estimated to be valued at US$ 15.88 billion in 2023 and is expected to exhibit a CAGR of 5.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Dynamics: One of the key driv...
Read more